Ferroptosis and Autoimmune Diseases. 2022

Benjamin Lai, and Chien-Hsiang Wu, and Chao-Yi Wu, and Shue-Fen Luo, and Jenn-Haung Lai
Department of Internal Medicine, Chang Gung Memorial Hospital, Taoyuan, Taiwan.

Adequate control of autoimmune diseases with an unclear etiology resulting from autoreactivation of the immune system remains a major challenge. One of the factors that trigger autoimmunity is the abnormal induction of cell death and the inadequate clearance of dead cells that leads to the exposure or release of intracellular contents that activate the immune system. Different from other cell death subtypes, such as apoptosis, necroptosis, autophagy, and pyroptosis, ferroptosis has a unique association with the cellular iron load (but not the loads of other metals) and preserves its distinguishable morphological, biological, and genetic features. This review addresses how ferroptosis is initiated and how it contributes to the pathogenesis of autoimmune diseases, including systemic lupus erythematosus, rheumatoid arthritis, and inflammatory bowel diseases. The mechanisms responsible for ferroptosis-associated events are discussed. We also cover the perspective of targeting ferroptosis as a potential therapeutic for patients with autoimmune diseases. Collectively, this review provides up-to-date knowledge regarding how ferroptosis occurs and its significance in autoimmune diseases.

UI MeSH Term Description Entries
D008180 Lupus Erythematosus, Systemic A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Libman-Sacks Disease,Lupus Erythematosus Disseminatus,Systemic Lupus Erythematosus,Disease, Libman-Sacks,Libman Sacks Disease
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000079403 Ferroptosis A form of REGULATED CELL DEATH initiated by oxidative perturbations of the intracellular microenvironment that is under constitutive control by glutathione peroxidase 4 and can be inhibited by iron chelators and lipophilic antioxidants. Oxytosis
D001327 Autoimmune Diseases Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides. Autoimmune Disease,Disease, Autoimmune,Diseases, Autoimmune
D015551 Autoimmunity Process whereby the immune system reacts against the body's own tissues. Autoimmunity may produce or be caused by AUTOIMMUNE DISEASES. Autoimmune Response,Autoimmune Responses,Autoimmunities
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis

Related Publications

Benjamin Lai, and Chien-Hsiang Wu, and Chao-Yi Wu, and Shue-Fen Luo, and Jenn-Haung Lai
April 2024, Annales de biologie clinique,
Benjamin Lai, and Chien-Hsiang Wu, and Chao-Yi Wu, and Shue-Fen Luo, and Jenn-Haung Lai
March 2020, International urology and nephrology,
Benjamin Lai, and Chien-Hsiang Wu, and Chao-Yi Wu, and Shue-Fen Luo, and Jenn-Haung Lai
April 2024, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
Benjamin Lai, and Chien-Hsiang Wu, and Chao-Yi Wu, and Shue-Fen Luo, and Jenn-Haung Lai
January 2023, Frontiers in immunology,
Benjamin Lai, and Chien-Hsiang Wu, and Chao-Yi Wu, and Shue-Fen Luo, and Jenn-Haung Lai
August 2022, Journal of translational medicine,
Benjamin Lai, and Chien-Hsiang Wu, and Chao-Yi Wu, and Shue-Fen Luo, and Jenn-Haung Lai
January 1987, La Revue de medecine interne,
Benjamin Lai, and Chien-Hsiang Wu, and Chao-Yi Wu, and Shue-Fen Luo, and Jenn-Haung Lai
January 2020, Frontiers in cellular neuroscience,
Benjamin Lai, and Chien-Hsiang Wu, and Chao-Yi Wu, and Shue-Fen Luo, and Jenn-Haung Lai
October 2020, Sheng li xue bao : [Acta physiologica Sinica],
Benjamin Lai, and Chien-Hsiang Wu, and Chao-Yi Wu, and Shue-Fen Luo, and Jenn-Haung Lai
January 2022, Journal of multidisciplinary healthcare,
Benjamin Lai, and Chien-Hsiang Wu, and Chao-Yi Wu, and Shue-Fen Luo, and Jenn-Haung Lai
February 2021, Signal transduction and targeted therapy,
Copied contents to your clipboard!